Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.

PubWeight™: 2.46‹?› | Rank: Top 2%

🔗 View Article (PMID 9087473)

Published in JAMA on April 09, 1997

Authors

D B Karpf1, D R Shapiro, E Seeman, K E Ensrud, C C Johnston, S Adami, S T Harris, A C Santora, L J Hirsch, L Oppenheimer, D Thompson

Author Affiliations

1: Merck Research Laboratories, Rahway, NJ 07065-0900, USA.

Articles citing this

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int (2008) 4.73

Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med (2011) 2.96

Advances in osteoporosis therapy. 2003 update of practical guidelines. Can Fam Physician (2003) 2.09

The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab (2005) 1.43

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study. J Bone Miner Metab (2005) 1.34

Bisphosphonate-associated femur fractures have high complication rates with operative fixation. Clin Orthop Relat Res (2012) 1.15

Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporos Int (2005) 1.09

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int (2004) 1.00

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int (2010) 0.97

Assessment of non-vertebral fracture risk in postmenopausal women. Ann Rheum Dis (2007) 0.92

Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy. Can Fam Physician (1998) 0.91

What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? Osteoporos Int (2010) 0.89

Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med (2010) 0.87

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect. Core Evid (2010) 0.85

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int (2005) 0.83

Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database. Clinicoecon Outcomes Res (2013) 0.80

The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer. Br J Cancer (2001) 0.79

Long-term recreational gymnastics provides a clear benefit in age-related functional decline and bone loss. A prospective 6-year study. Osteoporos Int (2006) 0.79

Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women. Clin Interv Aging (2006) 0.78

Bayesian decision analysis for choosing between diagnostic/prognostic prediction procedures. Stat Interface (2011) 0.78

Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment. PLoS One (2012) 0.78

Prevalence and predictors of osteoporosis risk in orthopaedic patients. Clin Orthop Relat Res (2010) 0.78

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations. Clin Interv Aging (2008) 0.77

Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation. Clin Interv Aging (2013) 0.77

Alendronate in the prevention of osteoporosis: 7-year follow-up. Osteoporos Int (2004) 0.76

Meta-analysis of prevention of nonvertebral fractures by alendronate. JAMA (1997) 0.75

Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial. J Korean Med Sci (2017) 0.75

Meta-analysis of prevention of nonvertebral fractures by alendronate. JAMA (1997) 0.75

Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines. CMAJ (2000) 0.75

Optimal decision criterion for detecting change in bone mineral density during serial monitoring: a Bayesian approach. Osteoporos Int (2008) 0.75

Articles by these authors

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA (1998) 19.64

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA (1999) 9.71

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57

Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int (1998) 7.14

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA (2001) 6.44

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet (2005) 6.18

Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17

Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res (1997) 5.69

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27

Esophagitis associated with the use of alendronate. N Engl J Med (1996) 4.89

Age and bone mass as predictors of fracture in a prospective study. J Clin Invest (1988) 4.46

Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med (1990) 4.10

Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (2000) 4.05

Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res (2000) 3.86

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67

Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med (1994) 3.62

Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology (2004) 3.60

Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2001) 3.46

What are the effects of the fifth revision of the Declaration of Helsinki? BMJ (2001) 3.17

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet (2009) 3.13

Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11

Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06

BMI from 3-6 y of age is predicted by TV viewing and physical activity, not diet. Int J Obes (Lond) (2005) 2.99

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone (2001) 2.81

Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80

Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int (2006) 2.79

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70

The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation. Crit Care Med (2000) 2.66

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med (1988) 2.66

Epidemiology of trauma deaths. Am J Surg (1980) 2.58

Bacterial infection in cystic fibrosis. Arch Dis Child (1972) 2.58

Screening for osteoporosis. Ann Intern Med (1990) 2.52

Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1997) 2.50

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res (2003) 2.50

A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol (2000) 2.47

Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47

Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med (2000) 2.46

The bone density of female twins discordant for tobacco use. N Engl J Med (1994) 2.44

A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology (2000) 2.44

Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) (1968) 2.39

Genetic factors in determining bone mass. J Clin Invest (1973) 2.35

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab (2000) 2.34

Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med (1989) 2.30

Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone (2000) 2.24

Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1998) 2.22

Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? J Biol Chem (1983) 2.22

The time course of a hypercalcaemic crisis in acute primary hyperparathyroidism. Lancet (1984) 2.21

Vitamin D and bone health in the elderly. Am J Clin Nutr (1982) 2.21

Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res (1995) 2.12

Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11

Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol (1996) 2.09

Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09

Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev (2006) 2.08

Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population. Clin Neurophysiol (2007) 2.07

American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version. J Clin Neurophysiol (2013) 2.07

Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis (1990) 2.04

Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res (1987) 2.03

Report on hypertension. Can Med Assoc J (1978) 2.01

Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00

Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res (1999) 1.95

The effect of mechanical loading on the size and shape of bone in pre-, peri-, and postpubertal girls: a study in tennis players. J Bone Miner Res (2002) 1.95

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91

Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures. Brain (2009) 1.89

Transforming the tobacco market: why the supply of cigarettes should be transferred from for-profit corporations to non-profit enterprises with a public health mandate. Tob Control (2005) 1.88

Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res (1998) 1.88

A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer (2006) 1.86

Role of physical activity in the development of skeletal mass in children. J Bone Miner Res (1991) 1.86

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation (2000) 1.85

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85

Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res (1991) 1.82

Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82

Importance of precision in bone density measurements. J Clin Densitom (2001) 1.82

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med (1998) 1.81

Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int (2005) 1.80

Experience with the ketogenic diet in infants. Pediatrics (2001) 1.80

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group. J Clin Oncol (1993) 1.79

Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts. J Bone Miner Res (1998) 1.77

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76

Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1999) 1.75

Calcium nutrition and bone health in the elderly. Am J Clin Nutr (1982) 1.74

High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care (2001) 1.74

Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty. Osteoporos Int (2001) 1.73

Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res (1997) 1.73

Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest (1997) 1.72

Evaluation of an institution-based protocol for postpartum rubella vaccination. CMAJ (2001) 1.71

Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int (1997) 1.71

Rationale, design and methods for process evaluation in the HEALTHY study. Int J Obes (Lond) (2009) 1.70

Association between aortic calcification and total and cardiovascular mortality in older women. J Intern Med (2007) 1.70